<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://www.medboundtimes.com/usa/body-mass-index-underestimates-obesity-levels-in-the-united-states</loc>
<image:image>
<image:loc>https://media.assettype.com/medbound/2026-06-02/3hya0k4x/pexels_anntarazevich_5629205__2_.webp</image:loc>
<image:caption><![CDATA[ Researchers analyzed data from over 5,600 adults, comparing BMI with waist and hip measurements to assess obesity risk.]]></image:caption>
</image:image>
<image:image>
<image:loc>https://media.assettype.com/medbound/2026-06-02/gcndgv86/pexels-polina-tankilevitch-6513400-1.webp</image:loc>
<image:caption><![CDATA[ Experts are questioning whether BMI alone can accurately identify people at risk for obesity-related health conditions.]]></image:caption>
</image:image>
<changefreq>hourly</changefreq>
<lastmod>2026-06-03T02:30:00.000Z</lastmod>
</url>
<url>
<loc>https://www.medboundtimes.com/medicine/glp-1-drugs-like-ozempic-beyond-weight-loss-science-vs-hype</loc>
<image:image>
<image:loc>https://media.assettype.com/medbound/2026-06-02/wa2wvrq3/haberdoedas_TzKc7FGaL7Y_unsplash__1_.webp</image:loc>
<image:caption><![CDATA[ While these medications show promise for a number of conditions, the evidence base is still emerging. ]]></image:caption>
</image:image>
<image:image>
<image:loc>https://media.assettype.com/medbound/2026-06-02/bb8ypd9b/pexels-pavel-danilyuk-7653670-1.webp</image:loc>
<image:caption><![CDATA[ Researchers are exploring whether GLP-1 drugs like Ozempic and Wegovy can help treat conditions beyond weight loss and diabetes.]]></image:caption>
</image:image>
<changefreq>hourly</changefreq>
<lastmod>2026-06-03T00:30:00.000Z</lastmod>
</url>
</urlset>